PURPOSEThe concept of mild cognitive impairment (MCI) has recently been introduced into the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) as mild neurocognitive disorder, making it a formal diagnosis. We investigated the prognostic value of such a diagnosis and analyzed the determinants of the future course of MCI in the AgeCoDe study (German Study on Ageing, Cognition, and Dementia in Primary Care Patients).
METHODSWe recruited 357 patients with MCI aged 75 years or older from primary care practices and conducted follow-up with interviews for 3 years. Depending on the course of impairment over time, the patients were retrospectively split into 4 groups representing remittent, fluctuating, stable, and progressive courses of MCI. We performed ordinal logistic regression analysis and classification and regression tree (CART) analysis.RESULTS Overall, 41.5% of the patients had remission of symptoms with normal cognitive function 1.5 and 3 years later, 21.3% showed a fluctuating course, 14.8% had stable symptoms, and 22.4% had progression to dementia. Patients were at higher risk for advancing from one course to the next along this spectrum if they had symptoms of depression, impairment in more than 1 cognitive domain, or more severe cognitive impairment, or were older. The result on a test of the ability to learn and reproduce new material 10 minutes later was the best indicator at baseline for differentiating between remittent and progressive MCI. Symptoms of depression modified the prognosis.
CONCLUSIONSIn primary care, about one-quarter of patients with MCI have progression to dementia within the next 3 years. Assessments of memory function and depressive symptoms are helpful in predicting a progressive vs a remittent course. When transferring the concept of MCI into clinical diagnostic algorithms (eg,, however, we should not forget that three-quarters of patients with MCI stayed cognitively stable or even improved within 3 years. They should not be alarmed unnecessarily by receiving such a diagnosis. 2014;158-165. doi:10.1370/afm.1596.
Ann Fam Med
INTRODUCTION
Mild cognitive impairment (MCI) is a common condition in the elderly with a prevalence of 16.0% in individuals without dementia 1 and an incidence rate of 63.6 (per 1,000 person-years). 2 It is considered to be a transitional state between normal and pathologic cognitive decline. MCI is defined by a cognitive performance below that expected for age and educational attainment, but above a pathologic level as in early dementia. Patients show essentially normal functional activities.Winblad et al 3 classified the clinical presentations of MCI into subtypes according to the impaired cognitive domains, such as memory, orientation, intellectual abilities, and higher cortical functioning. Taking into account memory deficits and the number of cognitive domains impaired, MCI subtypes have been classified as follows: amnestic single domain (impairment of memory only), amnestic multidomain (impairment of memory and 1 or more o...